{"id":"https://openalex.org/W2076028786","doi":"https://doi.org/10.1111/j.1365-2141.2008.07303.x","title":"The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma","display_name":"The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma","alternate_titles":[],"publication_year":2008,"publication_date":"2008-09-05","ids":{"openalex":"https://openalex.org/W2076028786","doi":"https://doi.org/10.1111/j.1365-2141.2008.07303.x","mag":"2076028786","pmid":"https://pubmed.ncbi.nlm.nih.gov/18673366"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2141.2008.07303.x","doi":"https://doi.org/10.1111/j.1365-2141.2008.07303.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2008.07303.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2008.07303.x","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2076028786"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2008.07303.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077846750","display_name":"Rub\u00e9n Niesvizky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ruben Niesvizky","raw_affiliation_strings":["Weill-Cornell Medical College of Cornell University, New York Presbyterian Hospital, New York, NY 10021, USA. run9001@med.cornell.edu","Weill\u2010Cornell Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill-Cornell Medical College of Cornell University, New York Presbyterian Hospital, New York, NY 10021, USA. run9001@med.cornell.edu","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295"]},{"raw_affiliation_string":"Weill\u2010Cornell Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043526996","display_name":"Paul Gerard Guy Richardson","orcid":"https://orcid.org/0000-0002-7426-8865","observed_orcids":["https://orcid.org/0000-0002-7426-8865"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul G. Richardson","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066940168","display_name":"S. Vincent Rajkumar","orcid":"https://orcid.org/0000-0002-5862-1833","observed_orcids":["https://orcid.org/0000-0002-5862-1833"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Vincent Rajkumar","raw_affiliation_strings":["Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082720713","display_name":"Morton Coleman","orcid":"https://orcid.org/0000-0002-8516-2513","observed_orcids":["https://orcid.org/0000-0002-8516-2513"]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Morton Coleman","raw_affiliation_strings":["Weill-Cornell Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill-Cornell Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015898454","display_name":"Laura Rosi\u00f1ol","orcid":"https://orcid.org/0000-0002-2534-9239","observed_orcids":["https://orcid.org/0000-0002-2534-9239"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laura Rosi\u00f1ol","raw_affiliation_strings":["Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210160192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002972322","display_name":"Pieter Sonneveld","orcid":"https://orcid.org/0000-0002-0808-2237","observed_orcids":["https://orcid.org/0000-0002-0808-2237"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pieter Sonneveld","raw_affiliation_strings":["Erasmus MC, Rotterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Erasmus MC, Rotterdam, the Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106408675","display_name":"Michael W. Schuster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael W. Schuster","raw_affiliation_strings":["Weill-Cornell Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill-Cornell Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109801302","display_name":"David H. Irwin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Irwin","raw_affiliation_strings":["Alta Bates Cancer Center, Berkeley, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alta Bates Cancer Center, Berkeley, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029801761","display_name":"Edward Allen Stadtmauer","orcid":"https://orcid.org/0000-0002-3935-6069","observed_orcids":["https://orcid.org/0000-0002-3935-6069"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Edward A. Stadtmauer","raw_affiliation_strings":["University of Pennsylvania Cancer Center, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania Cancer Center, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024315315","display_name":"Thierry T.F. Facon","orcid":"https://orcid.org/0000-0001-7705-8460","observed_orcids":["https://orcid.org/0000-0001-7705-8460"]},"institutions":[{"id":"https://openalex.org/I4210155195","display_name":"H\u00f4pital Claude Huriez","ror":"https://ror.org/05cpv3t46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thierry Facon","raw_affiliation_strings":["Hospital Claude Huriez, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Claude Huriez, Lille, France","institution_ids":["https://openalex.org/I4210155195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110474614","display_name":"Jean\u2010Luc Harousseau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean\u2010Luc Harousseau","raw_affiliation_strings":["Hotel Dieu Hospital, Nantes, France","H\u00f4tel-Dieu Hospital, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hotel Dieu Hospital, Nantes, France","institution_ids":[]},{"raw_affiliation_string":"H\u00f4tel-Dieu Hospital, Nantes, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109292881","display_name":"Anthony L. Boral","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anthony L. Boral","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090790045","display_name":"Dixie-Lee W. Esseltine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270001","display_name":"Takeda Oncology (United States)","ror":"https://ror.org/05vm7p871","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270001"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dixie\u2010Lee Esseltine","raw_affiliation_strings":["Millennium Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Millennium Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4405270001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031837957","display_name":"Joan Blad\u00e9","orcid":"https://orcid.org/0000-0002-4563-3405","observed_orcids":["https://orcid.org/0000-0002-4563-3405"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joan Blad\u00e9","raw_affiliation_strings":["Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210160192"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5077846750"],"corresponding_institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I205783295"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":6.9509,"has_fulltext":true,"cited_by_count":102,"citation_normalized_percentile":{"value":0.97304413,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"143","issue":"1","first_page":"46","last_page":"53"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9340000152587891},{"id":"https://openalex.org/keywords/relapsed-multiple-myeloma","display_name":"relapsed multiple myeloma","score":0.996999979019165},{"id":"https://openalex.org/keywords/treatment-free-interval","display_name":"treatment-free interval","score":0.8100000023841858},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.7889999747276306},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.949999988079071},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.9449999928474426},{"id":"https://openalex.org/keywords/very-good-partial-response","display_name":"very good partial response","score":0.875},{"id":"https://openalex.org/keywords/minimal-responses","display_name":"minimal responses","score":0.8970000147819519},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.7620000243186951},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.777999997138977}],"concepts":[{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.9333369731903076},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8756909370422363},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7851952314376831},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6986979842185974},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.6188920140266418},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.5083250403404236},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.45449745655059814},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.4495122730731964},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4394971430301666},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.43468719720840454},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42326968908309937},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4227769076824188},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3370193839073181},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.18054571747779846}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001897","descriptor_name":"Boronic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013995","descriptor_name":"Time","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016009","descriptor_name":"Chi-Square Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1365-2141.2008.07303.x","doi":"https://doi.org/10.1111/j.1365-2141.2008.07303.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2008.07303.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2008.07303.x","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:18673366","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18673366","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/c3d483d7-29e6-4a1b-b8c2-55af85946735","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1765/29160","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:eur:oai:pure.eur.nl:publications/c3d483d7-29e6-4a1b-b8c2-55af85946735","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/c3d483d7-29e6-4a1b-b8c2-55af85946735","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Haematology, 143(1), 46 - 53. Wiley-Blackwell Publishing Ltd","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2141.2008.07303.x","doi":"https://doi.org/10.1111/j.1365-2141.2008.07303.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2008.07303.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2008.07303.x","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320333265","display_name":"Takeda Oncology","ror":"https://ror.org/05vm7p871"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2076028786.pdf","grobid_xml":"https://content.openalex.org/works/W2076028786.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W20342555","https://openalex.org/W1978377409","https://openalex.org/W1998711466","https://openalex.org/W2010599622","https://openalex.org/W2012271436","https://openalex.org/W2016038211","https://openalex.org/W2017706891","https://openalex.org/W2039847348","https://openalex.org/W2044436186","https://openalex.org/W2048034122","https://openalex.org/W2066800926","https://openalex.org/W2081656034","https://openalex.org/W2102591890","https://openalex.org/W2108235071","https://openalex.org/W2111650326","https://openalex.org/W2120474651","https://openalex.org/W2124560610","https://openalex.org/W2132155854","https://openalex.org/W2134592456","https://openalex.org/W2136256331","https://openalex.org/W2147769421","https://openalex.org/W2163129932","https://openalex.org/W2186668219","https://openalex.org/W2247986604","https://openalex.org/W2321655863","https://openalex.org/W2322962980","https://openalex.org/W2333363976","https://openalex.org/W2555687110","https://openalex.org/W2555914769","https://openalex.org/W2584457840","https://openalex.org/W2586684086","https://openalex.org/W2592646916","https://openalex.org/W2994458539"],"related_works":["https://openalex.org/W2586684086","https://openalex.org/W2111650326","https://openalex.org/W4213356537","https://openalex.org/W2563483539","https://openalex.org/W2062373072","https://openalex.org/W2082682074","https://openalex.org/W2169231929","https://openalex.org/W2589057659","https://openalex.org/W2141247841","https://openalex.org/W2560929661"],"abstract_inverted_index":{"Quality":[0],"of":[1,24,32,44,82],"response":[2,45,84,92,98,104,216],"is":[3],"associated":[4,122],"with":[5,123,206],"prolonged":[6,161],"overall":[7],"survival":[8],"(OS)":[9],"in":[10,36,70,73,77,144,192,218],"newly":[11],"diagnosed":[12],"multiple":[13],"myeloma":[14,38,194],"patients.":[15],"This":[16],"cohort":[17],"study":[18],"within":[19],"the":[20,40,74],"phase":[21],"3":[22],"Assessment":[23],"Proteasome":[25],"Inhibition":[26],"for":[27,202],"Extending":[28],"Remissions":[29],"(APEX)":[30],"trial":[31],"bortezomib":[33,47,75,188],"versus":[34,138,184],"dexamethasone":[35],"relapsed":[37,193],"assessed":[39,69],"relationship":[41],"between":[42],"quality":[43],"to":[46,58,63,159,210],"(n":[48],"=":[49,87,95,101,107,118],"315)":[50],"and":[51,66,114,132,147,178],"clinical":[52,204],"benefit.":[53],"Treatment-free":[54],"interval":[55],"(TFI),":[56],"time":[57,62],"alternative":[59],"therapy":[60],"(TTAT),":[61],"progression":[64],"(TTP)":[65],"OS":[67,151,179],"were":[68],"response-evaluable":[71],"patients":[72],"arm":[76],"cohorts":[78],"defined":[79],"by":[80],"achievement":[81],"complete":[83],"(CR;":[85],"n":[86,94,100,106,117],"27),":[88],"very":[89],"good":[90],"partial":[91,97],"(VGPR;":[93],"31),":[96],"(PR;":[99],"77),":[102],"minimal":[103],"(MR;":[105],"21)":[108],"or":[109],"non-response":[110],"(NR,":[111],"including":[112],"stable":[113],"progressive":[115],"disease;":[116],"159).":[119],"CR":[120,196],"was":[121,142,152],"significantly":[124],"longer":[125],"median":[126,150,162],"TFI":[127,163],"(24.1":[128],"vs.":[129,135,165,170,175,181],"6.9/6.4":[130],"months)":[131,137,177,183],"TTAT":[133,168],"(27.1":[134],"13.6/14":[136],"VGPR/PR.":[139],"Median":[140],"TTP":[141,173],"similar":[143],"CR,":[145],"VGPR":[146],"PR":[148],"cohorts;":[149],"not":[153],"reached.":[154],"Patients":[155],"achieving":[156],"MR":[157,208],"appeared":[158,209],"have":[160],"(3.8":[164],"2.3":[166],"months),":[167,172],"(8.7":[169],"6.2":[171],"(4.9":[174],"2.8":[176],"(24.9":[180],"18.7":[182],"NR.":[185],"In":[186],"conclusion,":[187],"had":[189],"substantial":[190],"activity":[191],"patients;":[195],"may":[197],"be":[198,211],"a":[199,214],"surrogate":[200],"marker":[201],"significant":[203],"benefit":[205],"bortezomib.":[207],"valid":[212],"as":[213],"separate":[215],"category":[217],"this":[219],"setting.":[220]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2076028786","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":14}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
